Cargando…

Characterisation of anal intraepithelial neoplasia and anal cancer in HIV‐positive men by immunohistochemical markers p16, Ki‐67, HPV‐E4 and DNA methylation markers

Human papillomavirus (HPV)‐induced anal intraepithelial neoplasia (AIN, graded 1‐3) is highly prevalent in HIV‐positive (HIV+) men who have sex with men (MSM), but only a minority of lesions progresses to cancer. Our study aimed to characterise comprehensively anal tissue samples from a cross‐sectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Zee, Ramon P., Meijer, Chris J. L. M., Cuming, Tamzin, Kreuter, Alexander, van de Sandt, Miekel M., Quint, Wim G. V., de Vries, Henry J. C., Prins, Jan M., Steenbergen, Renske D. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2021
Materias:	Tumor Markers and Signatures
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292283/ https://www.ncbi.nlm.nih.gov/pubmed/34310698 http://dx.doi.org/10.1002/ijc.33748

Ejemplares similares

Classification of high‐grade cervical intraepithelial neoplasia by p16(ink4a), Ki‐67, HPV E4 and FAM19A4/miR124‐2 methylation status demonstrates considerable heterogeneity with potential consequences for management
por: Vink, Frederique J., et al.
Publicado: (2021)

Genome‐wide microRNA analysis of HPV‐positive self‐samples yields novel triage markers for early detection of cervical cancer
por: Snoek, Barbara C., et al.
Publicado: (2018)

Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA
por: Stoler, Mark H., et al.
Publicado: (2019)

DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population
por: Li, Na, et al.
Publicado: (2020)

FAM19A4/miR124‐2 methylation in invasive cervical cancer: A retrospective cross‐sectional worldwide study
por: Vink, Frederique J., et al.
Publicado: (2019)

Cancer‐associated fecal microbial markers in colorectal cancer detection
por: Eklöf, Vincy, et al.
Publicado: (2017)

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2017)

Role of quantitative p16(INK4A) mRNA assay and digital reading of p16(INK4A) immunostained sections in diagnosis of cervical intraepithelial neoplasia
por: Vasiljević, Nataša, et al.
Publicado: (2017)

Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell‐intrinsic properties
por: Eide, Peter W., et al.
Publicado: (2019)

Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer
por: Csizmarik, Anita, et al.
Publicado: (2022)

Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients
por: van Boxtel, Wim, et al.
Publicado: (2019)

Ovarian cancer‐derived copy number alterations signatures are prognostic in chemoradiotherapy‐treated head and neck squamous cell carcinoma
por: Essers, Paul B.M., et al.
Publicado: (2020)

Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
por: Strijker, Marin, et al.
Publicado: (2019)

Vesicle‐bound EBV‐BART13‐3p miRNA in circulation distinguishes nasopharyngeal from other head and neck cancer and asymptomatic EBV‐infections
por: Ramayanti, Octavia, et al.
Publicado: (2018)

Predictive value of chromosome 18q11.2‐q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer: A post hoc analysis of the randomized phase III‐trial AGITG‐MAX
por: van Dijk, Erik, et al.
Publicado: (2022)

Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer
por: Dings, Mark P. G., et al.
Publicado: (2022)

Capturing colorectal cancer inter‐tumor heterogeneity in patient‐derived xenograft (PDX) models
por: Prasetyanti, Pramudita R., et al.
Publicado: (2018)

Epstein‐Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin
por: Ramayanti, Octavia, et al.
Publicado: (2016)

IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer
por: Kruger, Dinja T., et al.
Publicado: (2019)

Decreased RORC expression and downstream signaling in HTLV‐1‐associated adult T‐cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?
por: Subramanian, Kritika, et al.
Publicado: (2018)

The topology of vitronectin: A complementary feature for neuroblastoma risk classification based on computer‐aided detection
por: Vicente‐Munuera, Pablo, et al.
Publicado: (2019)

Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
por: Eilertsen, Ina A., et al.
Publicado: (2018)

Clinical and molecular characteristics of estrogen receptor‐positive ultralow risk breast cancer tumors identified by the 70‐gene signature
por: Johansson, Annelie, et al.
Publicado: (2022)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma
por: Romani, Chiara, et al.
Publicado: (2022)

Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
por: Andree, Kiki C., et al.
Publicado: (2018)

The genetic tumor background is an important determinant for heterogeneous MYCN‐amplified neuroblastoma
por: Bogen, Dominik, et al.
Publicado: (2016)

High‐resolution imaging for the detection and characterisation of circulating tumour cells from patients with oesophageal, hepatocellular, thyroid and ovarian cancers
por: Dent, Barry M., et al.
Publicado: (2015)

Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early‐stage melanoma
por: Ortega‐Martínez, Idoia, et al.
Publicado: (2016)

Characterization of transcriptomic signature of primary prostate cancer analogous to prostatic small cell neuroendocrine carcinoma
por: Alshalalfa, Mohammed, et al.
Publicado: (2019)

Cancer Risk Stratification of Anal Intraepithelial Neoplasia in Human Immunodeficiency Virus–Positive Men by Validated Methylation Markers Associated With Progression to Cancer
por: van der Zee, Ramon P, et al.
Publicado: (2020)

High hemoglobin A1c levels within the non‐diabetic range are associated with the risk of all cancers
por: Goto, Atsushi, et al.
Publicado: (2015)

Protein Z: A putative novel biomarker for early detection of ovarian cancer
por: Russell, Matthew R., et al.
Publicado: (2016)

Increased breast cancer screening and downstaging in Colombian women: A randomized trial of opportunistic breast‐screening
por: Murillo, Raúl, et al.
Publicado: (2015)

Validation of a DNA methylation HPV triage classifier in a screening sample
por: Lorincz, Attila T., et al.
Publicado: (2016)

Distinct and shared three‐dimensional chromosome organization patterns in lymphocytes, monoclonal gammopathy of undetermined significance and multiple myeloma
por: Sathitruangsak, Chirawadee, et al.
Publicado: (2016)

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
por: Stangl, Stefan, et al.
Publicado: (2017)

Whole blood FPR1 mRNA expression predicts both non‐small cell and small cell lung cancer
por: Morris, Scott, et al.
Publicado: (2018)

Intraductal papillary mucinous neoplasm of the pancreas rapidly xenografts in chicken eggs and predicts aggressiveness
por: Zhao, Zhefu, et al.
Publicado: (2017)

Assessment of early response biomarkers in relation to long‐term survival in patients with HER2‐negative breast cancer receiving neoadjuvant chemotherapy plus bevacizumab: Results from the Phase II PROMIX trial
por: Kimbung, Siker, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6dv0n28so49nesm4vm6jf6gisd